For example, studies have shown that inhibition of DHODH leads to effective growth suppression in certain types of cancers, including isocitrate dehydrogenase mutant glioma, diffuse midline glioma, and a KRAS-driven PDAC model (15–17). Here, DHODH is linked to cancer.